Illustration of the tumur microenvironment in triple-negative breast

$ 13.50

4.9 (774) In stock

Download scientific diagram | Illustration of the tumur microenvironment in triple-negative breast cancer. Notes: Data from Zhou Y, Tian Q, Wang BY, Yang J, Zhao SD, Yang J. The prognostic significance of TILs as a biomarker in triple-negative breast cancer: what is the role of TILs in TME of TNBC? Adapted from Zhou Y, Tian Q, Wang BY, Yang J, Zhao SD, Yang J. The prognostic significance of TILs as a biomarker in triple-negative breast cancer: what is the role of TILs in TME of TNBC. Eur Rev Med Pharmacol Sci. 2021;25(7):2885-2897. Creative Commons. 7 from publication: Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management | Triple negative breast cancer (TNBC) is a subtype of breast cancer which does not express or expresses a minimum amount of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) protein. TNBCs include a heterogenic group of | Breast Cancer Management, Triple Negative Breast Neoplasms and Tumor-Infiltrating Lymphocytes | ResearchGate, the professional network for scientists.

Frontiers Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer

Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes

Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressiveness - Materials Today

Crosstalk between triple negative breast cancer and microenvironment

Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer - ScienceDirect

Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model - ScienceDirect

Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents - ScienceDirect

The updated landscape of tumor microenvironment and drug repurposing

Initial Results from Phase 2 Mechanism of Action Trial in

Repurposed drug shows improved results with combined therapy for triple negative breast cancer

Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches